Group One Trading, L.P. Supernus Pharmaceuticals, Inc. Transaction History

Group One Trading, L.P.

$2.54 Billion
Q4 2024

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$22.72 - $29.68 $19,357 - $25,287	852 New	852 $24,000
Q1 2023 May 12, 2023	SELL	$34.93 - $42.03 $48,412 - $58,253	-1,386 Reduced 92.46%	113 $4,000
Q4 2022 Feb 09, 2023	SELL	$31.09 - $37.88 $907,734 - $1.11 Million	-29,197 Reduced 95.12%	1,499 $53,000
Q3 2022 Nov 09, 2022	SELL	$28.79 - $35.41 $880,283 - $1.08 Million	-30,576 Reduced 49.9%	30,696 $1.04 Million
Q2 2022 Aug 11, 2022	BUY	$25.33 - $34.25 $1.52 Million - $2.05 Million	59,984 Added 4657.14%	61,272 $1.77 Million
Q1 2022 May 12, 2022	SELL	$28.51 - $32.9 $34,212 - $39,480	-1,200 Reduced 48.23%	1,288 $42,000
Q4 2021 Feb 11, 2022	SELL	$26.37 - $34.22 $48,810 - $63,341	-1,851 Reduced 42.66%	2,488 $73,000
Q3 2021 Nov 12, 2021	BUY	$23.54 - $31.39 $102,140 - $136,201	4,339 New	4,339 $116,000
Q2 2021 Aug 10, 2021	SELL	$26.72 - $33.19 $42,324 - $52,572	-1,584 Closed	0 $0
Q1 2021 May 12, 2021	BUY	$24.15 - $31.45 $20,261 - $26,386	839 Added 112.62%	1,584 $41,000
Q4 2020 Feb 10, 2021	SELL	$17.7 - $25.81 $9,150 - $13,343	-517 Reduced 40.97%	745 $19,000
Q3 2020 Nov 12, 2020	SELL	$20.2 - $25.05 $207,817 - $257,714	-10,288 Reduced 89.07%	1,262 $26,000
Q2 2020 Aug 13, 2020	SELL	$17.09 - $24.89 $194,415 - $283,148	-11,376 Reduced 49.62%	11,550 $274,000
Q1 2020 May 13, 2020	SELL	$14.45 - $24.69 $842,926 - $1.44 Million	-58,334 Reduced 71.79%	22,926 $412,000
Q4 2019 Feb 10, 2020	BUY	$19.93 - $29.13 $1.41 Million - $2.06 Million	70,842 Added 680.0%	81,260 $1.93 Million
Q3 2019 Nov 12, 2019	BUY	$25.47 - $33.37 $132,545 - $173,657	5,204 Added 99.81%	10,418 $286,000
Q2 2019 Aug 09, 2019	SELL	$29.96 - $38.87 $7,789 - $10,106	-260 Reduced 4.75%	5,214 $173,000
Q1 2019 May 13, 2019	SELL	$32.77 - $41.99 $356,635 - $456,977	-10,883 Reduced 66.53%	5,474 $192,000
Q4 2018 Feb 06, 2019	BUY	$30.84 - $49.51 $436,848 - $701,309	14,165 Added 646.21%	16,357 $543,000
Q3 2018 Nov 08, 2018	BUY	$42.7 - $56.55 $93,598 - $123,957	2,192 New	2,192 $110,000
Q1 2018 May 11, 2018	SELL	$37.15 - $46.9 $16,940 - $21,386	-456 Closed	0 $0
Q4 2017 Feb 09, 2018	SELL	$36.4 - $42.6 $16,452 - $19,255	-452 Reduced 49.78%	456 $18,000
Q3 2017 Nov 15, 2017	BUY	$36.75 - $49.65 $33,369 - $45,082	908	908 $36,000

Others Institutions Holding SUPN

# of Institutions

302

Shares Held

60.6M

Call Options Held

25.2K

Put Options Held

2.6K

Black Rock Inc. New York, NY

10.4M
Shares

$406 Million
0.01% of portfolio
Vanguard Group Inc Valley Forge, PA

6.15M
Shares

$241 Million
0.0% of portfolio
Armistice Capital, LLC New York, NY

4.84M
Shares

$189 Million
2.47% of portfolio
Dimensional Fund Advisors LP Austin, TX

2.88M
Shares

$113 Million
0.03% of portfolio
Macquarie Group LTD Australia, C3

2.63M
Shares

$103 Million
0.11% of portfolio

View Full List

About SUPERNUS PHARMACEUTICALS, INC.

Ticker SUPN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 53,495,300
Market Cap $2.09B
Description
Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. Its commercial products are Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prop...

More about SUPN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Group One Trading, L.P. with notifications on news.

Account